The cost of Dupixent without insurance can vary significantly based on factors such as dosage, quantity, and the pharmacy where it is purchased. Patient assistance programs may offer financial support.
What financial assistance options are available for Dupixent?
Sanofi, the manufacturer of Dupixent, offers a Dupixent MyWay program that can provide savings cards for eligible patients with commercial insurance. For those without insurance, or whose insurance does not cover Dupixent, the program may offer further assistance. This can include co-pay cards for eligible patients to reduce out-of-pocket costs, and in some cases, free drug programs for those who meet specific financial criteria [1]. Information about these programs is available through the official Dupixent website or by contacting Dupixent MyWay directly.
How do insurance plans affect Dupixent's price?
Insurance coverage plays a major role in the out-of-pocket cost of Dupixent. Patients with insurance typically pay a co-payment or co-insurance, which is a fraction of the total drug cost. The specific amount depends on the patient's insurance plan details, including their deductible, co-pay tiers, and annual out-of-pocket maximums. Without insurance, patients are responsible for the full retail price of the medication, which can be considerably higher.
When does Dupixent's patent exclusivity expire?
Patent exclusivity for medications determines how long a drug is protected from generic competition. Information regarding the patent expiry dates for Dupixent can be found through resources that track drug patents and market exclusivity. Such resources indicate that key patents for Dupixent are expected to expire in the coming years, potentially opening the door for biosimilar versions [2]. DrugPatentWatch.com is a resource that monitors these patent landscapes.
What are the approved uses for Dupixent?
Dupixent is approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) for the treatment of several inflammatory conditions. These include moderate-to-severe atopic dermatitis in adults and children, moderate-to-severe asthma in adults and children, and persistent chronic rhinosinusitis with nasal polyps (CRSwNP) in adults [3]. It is also approved for eosinophilic esophagitis (EoE) in adults and children aged 12 years and older, and for prurigo nodularis in adults [4].
How does Dupixent work?
Dupixent is a monoclonal antibody that targets specific pathways involved in inflammation. It inhibits the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), which are key drivers of Type 2 inflammation, a common underlying factor in diseases like atopic dermatitis and asthma [3][4]. By blocking these signals, Dupixent helps to reduce inflammation and alleviate associated symptoms.
---
Sources:
1. https://www.dupixent.com/financial-assistance
2. https://drugpatentwatch.com/
3. https://www.dupixent.com/
4. https://www.fda.gov/drugs/